InfuSystem

InfuSystem is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care. The Company provides its products and services to hospitals, oncology practices and facilities and other alternate site health care providers. In addition, InfuSystem sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance, and repair services for oncology practices as well as other alternate site settings including home care and home infusion providers, skilled nursing facilities, pain centers and others. The Company also provides these products and services to customers in the hospital market.

Company Growth (employees)
Type
Public
HQ
Madison Heights, US
Founded
2005
Size (employees)
238 (est)-1%
InfuSystem was founded in 2005 and is headquartered in Madison Heights, US

InfuSystem Office Locations

InfuSystem has an office in Madison Heights
Madison Heights, US (HQ)
31700 Research Park Dr

InfuSystem Data and Metrics

InfuSystem Financial Metrics

InfuSystem's revenue was reported to be $17.7 m in Q1, 2017
USD

Revenue (Q1, 2017)

17.7 m

Net income (Q1, 2017)

(1.5 m)

EBIT (Q1, 2017)

(2 m)

Market capitalization (15-Aug-2017)

44.3 m

Cash (31-Mar-2017)

194 k
InfuSystem's current market capitalization is $44.3 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

62.3 m66.5 m72.1 m70.5 m

Revenue growth, %

7%8%(2%)

General and administrative expense

24.6 m

Operating expense total

24.6 m

EBIT

5.9 m9.3 m8.9 m974 k

EBIT margin, %

9%14%12%1%

Interest expense

3.5 m3.1 m1.7 m(1.3 m)

Pre tax profit

2.7 m6.2 m5.6 m(364 k)

Income tax expense

(1 m)(2.9 m)(1.8 m)142 k

Net Income

1.7 m3.4 m3.7 m(222 k)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

16.4 m16.6 m16.7 m17.2 m18.7 m19 m19.1 m17.2 m17.7 m

General and administrative expense

4.9 m4.9 m6 m6 m5.7 m6.7 m6.4 m5.3 m6.5 m

Operating expense total

4.9 m4.9 m6 m6 m5.7 m6.7 m6.4 m5.3 m6.5 m

EBIT

2.3 m2.4 m1.6 m1.3 m2.7 m1.2 m1.4 m576 k(2 m)

EBIT margin, %

14%15%9%8%15%6%7%3%(11%)

Interest expense

(776 k)(752 k)(672 k)(387 k)(338 k)(305 k)(327 k)(384 k)(328 k)

Pre tax profit

1.7 m(700 k)930 k2.3 m879 k1.1 m186 k(2.3 m)

Income tax expense

(842 k)285 k(147 k)(957 k)(384 k)(337 k)(130 k)856 k

Net Income

886 k852 k(415 k)783 k1.4 m495 k724 k56 k(1.5 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

1.1 m515 k818 k3.4 m

Inventories

1.2 m1.8 m1.9 m2.2 m

Current Assets

15.9 m15.5 m20.5 m20.8 m

Total Assets

77.4 m80.2 m96.4 m96.3 m

Accounts Payable

4.7 m5.2 m6.6 m5.3 m

Total Debt

26.7 m25.5 m34.9 m31.9 m

Current Liabilities

13 m14.7 m15.3 m16.4 m

Non-Current Liabilities

29.2 m

Total Liabilities

45.7 m

Additional Paid-in Capital

89.8 m90.2 m91.2 m91.8 m

Retained Earnings

(47.1 m)(43.7 m)(40 m)(41.1 m)

Total Equity

42.7 m46.5 m51.3 m50.7 m

Debt to Equity Ratio

0.6 x0.5 x0.7 x0.6 x

Debt to Assets Ratio

0.3 x0.3 x0.4 x0.3 x

Financial Leverage

1.8 x1.7 x1.9 x1.9 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

1 m1.9 m3.2 m791 k989 k569 k805 k1.1 m194 k

Inventories

1.5 m1.6 m2 m1.9 m1.9 m2.6 m2.1 m2.1 m2.1 m

Current Assets

16.3 m17.9 m20.1 m18.3 m19.6 m22.4 m23.8 m19.4 m15.7 m

Goodwill

3.6 m1 m

Total Assets

77.7 m81 m87.5 m91.8 m93.8 m100.2 m100.3 m97.1 m91.9 m

Accounts Payable

4.1 m4.6 m5.4 m6.3 m5.5 m8 m5.3 m4.7 m4.9 m

Current Liabilities

10.5 m12.1 m13.1 m16.2 m14.8 m15.7 m13.8 m14.7 m40.1 m

Non-Current Liabilities

2.1 m

Additional Paid-in Capital

90 m90 m90.4 m90.8 m91 m91.5 m91.7 m91.6 m92 m

Retained Earnings

(45.6 m)(44.7 m)(44.1 m)(43.3 m)(42 m)(39.5 m)(38.7 m)(40.7 m)(42.4 m)

Total Equity

44.4 m45.3 m46.3 m47.5 m49 m52.1 m52.9 m51 m49.6 m

Financial Leverage

1.8 x1.8 x1.9 x1.9 x1.9 x1.9 x1.9 x1.9 x1.9 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

1.7 m3.4 m3.7 m(222 k)

Depreciation and Amortization

2.6 m2.5 m2.9 m3.8 m

Accounts Receivable

(8.7 m)(5.4 m)(9.1 m)(4.6 m)

Inventories

105 k(524 k)(158 k)(250 k)

Accounts Payable

(1.1 m)(4 m)(2.8 m)(3.1 m)

Cash From Operating Activities

7.5 m7.3 m7.1 m7.9 m

Purchases of PP&E

(6.2 m)(370 k)

Cash From Investing Activities

(2.2 m)(2.8 m)(11.9 m)(5.3 m)

Cash From Financing Activities

(6.5 m)(5 m)5.2 m15 k

Interest Paid

2.7 m2.4 m1.5 m1.2 m

Income Taxes Paid

549 k298 k146 k105 k
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

886 k852 k(415 k)783 k1.4 m495 k724 k56 k(1.5 m)

Depreciation and Amortization

625 k622 k631 k713 k756 k912 k922 k958 k1.4 m

Inventories

1.5 m1.6 m2 m1.9 m1.9 m2.6 m2.1 m2.1 m2.1 m

Accounts Payable

4.1 m4.6 m5.4 m6.3 m5.5 m8 m5.3 m4.7 m4.9 m
USDY, 2017

Revenue/Employee

73.6 k

Financial Leverage

1.9 x

InfuSystem Operating Metrics

FY, 2016

Clinics

1.8 k

Rental Services

70

InfuSystem Market Value History

Traffic Overview of InfuSystem

InfuSystem Online and Social Media Presence

InfuSystem Company Life and Culture

You may also be interested in